Table 1 Assessment questions on coherence and alignment with the Special Programme of Research and Training in Tropical Diseases (TDR)
From: Building coherence and synergy among global health initiatives
Overall objectives | |
Mandate | Is the mandate of the GHI compatible with TDR’s mandate? |
Principles/values | Are the guiding principles/values compatible with TDR? |
Priorities | Are the priorities relevant for TDR and/or reflect trending priorities in global health, such as system approaches, preventions, universal health coverage and sustainable development goals? |
Nature/scope of membership | Do the nature and scope of membership conflict with TDR’s interests? Does the GHI operate through partnerships and networks? |
Inclusiveness | Is there a balanced representation between high- and low/middle-income countries? |
Target | |
Disease and technologies | Is the diseases and technology profile/portfolio compatible with TDR’s current portfolio and possible expansion? |
Beneficiary geographical area | Are the beneficiaries of support compatible with TDR’s focus? |
Beneficiary eligibility | To what extent would the beneficiaries reinforce/expand the current scope of TDR? |
Harmonization | Are there attempts to harmonize process and activities with partners? |
Processes | |
Decision-making (policy and strategy) | Is the policy and strategy decision-making process consistent with TDR’s principles? |
Prioritization (programme level) | Is the decision-making process at the programmatic level consistent with TDR? |
Decision-making for grants | Is the decision-making process at the project level consistent with TDR? |
Business model | Is there any aspect of the business model that could restrict TDR from engaging? |
Type of support | Do the funding mechanisms conflict with TDR? Can the funding mechanisms add value to TDR? |
Areas of work | |
Capacity building | Would the range of capacity building activities add a value to TDR’s current approaches? If so, what kind of added value? |
Knowledge management | Would the range of knowledge management add a value to TDR’s current approaches? If so, what kind of added value? |
Translational research | Is the research and funding covering translational research? And if so, any evidence of success? |
Funding and outlook | |
Global Health Initiative (GHI) outreach | Would engagement with the GHI add another value for strengthening TDR’s influence in global health (e.g. agenda setting, networking, etc.)? |
Funding | Would the engagement with the GHI offer the prospect of additional funding for TDR? |
Business trend | Is there a risk for TDR to engage with the GHI? (e.g. sustainability, reputation costs)? |